NCT04731922View on ClinicalTrials.gov

A Study of TAK-510 in Healthy Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

124

Participants

Timeline

Start Date

February 3, 2021

Primary Completion Date

July 24, 2022

Study Completion Date

July 24, 2022

Conditions

Healthy Participants

Interventions

DRUG

TAK-510

TAK-510 solution.

DRUG

TAK-510 Placebo

TAK-510 placebo-matching solution.

Trial Locations (2)

78744

PPD Development, LP, Austin

89113

PPD Development, LP, Las Vegas

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY